CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
US Bahasa Indonesia
Negara • United States
    Entitas • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Citius Pharmaceuticals, Inc. - CTXR CFD

    1.2062
    2.42%
    0.0176
    Rendah: 1.1863
    Tinggi: 1.2361
    Market Trading Hours* (UTC) Opens on Monday at 13:30

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0176
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.025457%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.003235%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Citius Pharmaceuticals Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

    Key Stats
    Prev. Close* 1.2361
    Open* 1.2261
    1-Year Change* 21.4%
    Day's Range* 1.1863 - 1.2361
    52 wk Range 0.77-1.71
    Average Volume (10 days) 1.18M
    Average Volume (3 months) 30.97M
    Market Cap 198.57M
    P/E Ratio -100.00K
    Shares Outstanding 158.86M
    Revenue N/A
    EPS -0.21
    Dividend (Yield %) N/A
    Beta 1.39
    Next Earnings Date Aug 9, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Jun 9, 2023 1.2062 -0.0399 -3.20% 1.2461 1.2461 1.1863
    Jun 8, 2023 1.2361 -0.0299 -2.36% 1.2660 1.2760 1.2261
    Jun 7, 2023 1.2660 0.0000 0.00% 1.2660 1.2959 1.2660
    Jun 6, 2023 1.2760 0.0100 0.79% 1.2660 1.2959 1.2560
    Jun 5, 2023 1.2660 -0.0200 -1.56% 1.2860 1.3358 1.2660
    Jun 2, 2023 1.2859 0.0398 3.19% 1.2461 1.3059 1.2162
    Jun 1, 2023 1.2361 0.0897 7.82% 1.1464 1.2959 1.1364
    May 31, 2023 1.1364 0.0399 3.64% 1.0965 1.1464 1.0965
    May 30, 2023 1.0965 -0.0100 -0.90% 1.1065 1.1364 1.0965
    May 26, 2023 1.1065 0.0299 2.78% 1.0766 1.1165 1.0766
    May 25, 2023 1.0766 -0.0498 -4.42% 1.1264 1.1264 1.0666
    May 24, 2023 1.1065 0.0200 1.84% 1.0865 1.1364 1.0666
    May 23, 2023 1.0965 -0.0299 -2.65% 1.1264 1.1464 1.0666
    May 22, 2023 1.1264 -0.0399 -3.42% 1.1663 1.1763 1.1264
    May 19, 2023 1.1663 0.0199 1.74% 1.1464 1.1763 1.1264
    May 18, 2023 1.1165 0.0100 0.90% 1.1065 1.1564 1.0866
    May 17, 2023 1.0866 -0.1694 -13.49% 1.2560 1.2561 1.0467
    May 16, 2023 1.2461 0.0000 0.00% 1.2461 1.2660 1.2261
    May 15, 2023 1.2660 -0.1296 -9.29% 1.3956 1.4056 1.2261
    May 12, 2023 1.3956 0.0498 3.70% 1.3458 1.4355 1.2860

    Citius Pharmaceuticals, Inc. Events

    Time (UTC) Country Event
    Wednesday, August 9, 2023

    Time (UTC)

    10:59

    Country

    US

    Event

    Q3 2023 Citius Pharmaceuticals Inc Earnings Release
    Q3 2023 Citius Pharmaceuticals Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0 0 0 0 0
    Revenue 0 0 0 0 0
    Total Operating Expense 33.3161 23.3653 17.7107 15.5984 13.3391
    Selling/General/Admin. Expenses, Total 15.6606 11.2914 8.89788 7.00146 7.22622
    Research & Development 17.6555 12.2405 8.81281 8.5969 6.56293
    Operating Income -33.3161 -23.3653 -17.7107 -15.5984 -13.3391
    Interest Income (Expense), Net Non-Operating 0.2514 0.25099 0.0524 0.03622 -0.01584
    Net Income Before Taxes -33.0647 -23.0544 -17.5481 -15.5621 -12.5366
    Net Income After Taxes -33.6407 -23.0544 -17.5481 -15.5621 -12.5366
    Net Income Before Extra. Items -33.6407 -23.0544 -17.5481 -15.5621 -12.5366
    Net Income -33.6407 -23.0544 -17.5481 -15.5621 -12.5366
    Income Available to Common Excl. Extra. Items -33.6407 -24.5053 -17.5481 -15.5621 -12.5366
    Income Available to Common Incl. Extra. Items -33.6407 -24.5053 -17.5481 -15.5621 -12.5366
    Diluted Net Income -33.6407 -24.5053 -17.5481 -15.5621 -12.5366
    Diluted Weighted Average Shares 146.082 108.599 39.1652 20.1618 10.7319
    Diluted EPS Excluding Extraordinary Items -0.23029 -0.22565 -0.44805 -0.77186 -1.16817
    Diluted Normalized EPS -0.23029 -0.22718 -0.44805 -0.77186 -1.2101
    Unusual Expense (Income) 0 -0.16656 0 -0.45
    Other, Net 0 0.05992 0.11021 0 0.81834
    Total Adjustments to Net Income 0 -1.45088
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total revenue 0 0 0 0 0
    Revenue 0 0 0 0 0
    Total Operating Expense 10.6853 3.66419 7.54957 8.91665 7.59063
    Selling/General/Admin. Expenses, Total 5.95845 3.80437 3.69234 4.02846 4.13842
    Research & Development 4.72686 3.44552 3.85723 4.88819 3.45221
    Operating Income -10.6853 -3.66419 -7.54957 -8.91665 -7.59063
    Interest Income (Expense), Net Non-Operating 0.30328 0.21455 0.13483 0.05302 0.02957
    Other, Net 0 0
    Net Income Before Taxes -10.382 -3.44965 -7.41474 -8.86363 -7.56105
    Net Income After Taxes -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    Net Income Before Extra. Items -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    Net Income -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    Income Available to Common Excl. Extra. Items -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    Income Available to Common Incl. Extra. Items -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    Diluted Net Income -10.526 -3.59365 -7.99074 -8.86363 -7.56105
    Diluted Weighted Average Shares 146.252 146.211 146.146 146.13 146.042
    Diluted EPS Excluding Extraordinary Items -0.07197 -0.02458 -0.05468 -0.06066 -0.05177
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.07197 -0.04052 -0.05468 -0.06066 -0.05177
    Total Adjustments to Net Income 0 0
    Unusual Expense (Income) 0 -3.58569 0
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 44.5643 72.8143 13.982 7.94192 10.0601
    Cash and Short Term Investments 41.7117 70.073 13.8597 7.8938 9.184
    Cash & Equivalents 41.7117 70.073 13.8597 7.8938 9.184
    Prepaid Expenses 2.85258 2.7414 0.12224 0.04811 0.05773
    Total Assets 113.999 142.429 43.7737 36.7464 31.0505
    Property/Plant/Equipment, Total - Net 0.65017 0.82985 0.98778 0.00059 0.00148
    Property/Plant/Equipment, Total - Gross
    Accumulated Depreciation, Total
    Goodwill, Net 9.3468 9.3468 9.3468 9.3468 1.5868
    Intangibles, Net 59.4 59.4 19.4 19.4 19.4
    Other Long Term Assets, Total 0.03806 0.03806 0.05709 0.05709 0.00217
    Total Current Liabilities 4.53001 3.98229 4.09713 4.60772 3.18484
    Accounts Payable 1.16538 1.2771 1.85624 2.71354 1.57344
    Accrued Expenses 3.36463 2.7052 2.06793 1.72121 1.43843
    Notes Payable/Short Term Debt 0 0 0.17297 0.17297 0.17297
    Other Current Liabilities, Total 0
    Total Liabilities 11.1734 10.2467 10.103 9.59352 3.18484
    Total Long Term Debt 0 0 0.16458 0 0
    Total Equity 102.826 132.182 33.6707 27.1529 27.8657
    Preferred Stock - Non Redeemable, Net 0 0 0
    Common Stock 0.14621 0.14598 0.05558 0.02893 0.0162
    Additional Paid-In Capital 232.368 228.084 104.209 80.1697 68.1073
    Retained Earnings (Accumulated Deficit) -129.688 -96.0478 -70.5939 -53.0458 -40.2578
    Total Liabilities & Shareholders’ Equity 113.999 142.429 43.7737 36.7464 31.0505
    Total Common Shares Outstanding 146.211 145.979 55.577 28.9305 16.1988
    Total Receivables, Net 0.81834
    Long Term Debt 0 0.16458 0
    Deferred Income Tax 5.5618 4.9858 4.9858 4.9858
    Other Liabilities, Total 0.48125 0.67823 0.85547
    Minority Interest 0.60038 0.60038
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 34.9011 42.3174 44.5643 50.8345 58.2593
    Cash and Short Term Investments 29.0655 36.8872 41.7117 48.0442 55.7562
    Cash & Equivalents 29.0655 36.8872 41.7117 48.0442 55.7562
    Prepaid Expenses 5.8356 5.43013 2.85258 2.79032 2.50311
    Total Assets 104.241 111.705 113.999 120.316 127.786
    Property/Plant/Equipment, Total - Net 0.55484 0.60299 0.65017 0.69642 0.74177
    Goodwill, Net 9.3468 9.3468 9.3468 9.3468 9.3468
    Intangibles, Net 59.4 59.4 59.4 59.4 59.4
    Other Long Term Assets, Total 0.03806 0.03806 0.03806 0.03806 0.03806
    Total Current Liabilities 6.20968 4.53717 4.53001 4.46112 4.02192
    Accounts Payable 2.72559 1.53758 1.16538 1.69052 1.70513
    Accrued Expenses 3.48408 2.99959 3.36463 2.7706 2.3168
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 13.0347 11.2719 11.1734 10.5802 10.1904
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt
    Deferred Income Tax 5.8498 5.7058 5.5618 4.9858 4.9858
    Minority Interest 0.60038 0.60038 0.60038 0.60038 0.60038
    Other Liabilities, Total 0.37483 0.42857 0.48125 0.53288 0.5823
    Total Equity 91.2061 100.433 102.826 109.736 117.596
    Preferred Stock - Non Redeemable, Net 0 0 0 0
    Common Stock 0.14636 0.14621 0.14621 0.14613 0.14613
    Additional Paid-In Capital 234.868 233.569 232.368 231.287 230.284
    Retained Earnings (Accumulated Deficit) -143.808 -133.282 -129.688 -121.698 -112.834
    Total Liabilities & Shareholders’ Equity 104.241 111.705 113.999 120.316 127.786
    Total Common Shares Outstanding 146.358 146.211 146.211 146.13 146.13
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -33.6407 -23.0544 -17.5481 -15.5621 -12.5366
    Cash From Operating Activities -28.3613 -24.2504 -16.9307 -12.4377 -11.3181
    Cash From Operating Activities 0.00292 0.00149 0.00084 0.00089 0.00175
    Non-Cash Items 4.46091 1.5198 1.48355 0.92758 0.7069
    Cash Taxes Paid
    Cash Interest Paid 0 0.00019
    Changes in Working Capital 0.23956 -2.71727 -0.86697 2.19592 0.50985
    Cash From Investing Activities 0 -40.0069 -0.00183 0 0
    Other Investing Cash Flow Items, Total 0
    Cash From Financing Activities 0 120.471 22.8984 11.1475 17.298
    Financing Cash Flow Items 0 18.4504 0 0
    Issuance (Retirement) of Debt, Net 0 -0.17297 0.16458 0 0
    Net Change in Cash -28.3613 56.2132 5.96594 -1.2902 5.9799
    Capital Expenditures 0 -40.0069 -0.00183 0 0
    Issuance (Retirement) of Stock, Net 0 102.193 22.7339 11.1475 17.298
    Deferred Taxes 0.576
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -14.1197 -3.59365 -33.6407 -25.6499 -16.7863
    Cash From Operating Activities -12.6774 -4.82444 -28.3613 -22.0287 -14.3167
    Cash From Operating Activities 0.00146 0.00073 0.00292 0.00219 0.00146
    Non-Cash Items 2.56255 1.24754 4.46091 3.3344 2.28611
    Changes in Working Capital -1.40977 -2.62306 0.23956 0.28456 0.18199
    Cash From Financing Activities 0.03127 0 0 0 0
    Financing Cash Flow Items 0 0 0 0
    Issuance (Retirement) of Stock, Net 0.03127 0 0 0
    Issuance (Retirement) of Debt, Net 0 0 0
    Net Change in Cash -12.6462 -4.82444 -28.3613 -22.0287 -14.3167
    Cash From Investing Activities 0 0 0
    Capital Expenditures 0 0
    Deferred Taxes 0.288 0.144 0.576
    Other Investing Cash Flow Items, Total 0
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Mazur (Leonard L) Individual Investor 6.4557 10255342 -1 2022-11-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.8112 6054328 40301 2023-03-31 LOW
    Armistice Capital LLC Hedge Fund 1.5265 2425000 -3743361 2021-12-31 HIGH
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.4586 2317168 4868 2023-03-31 LOW
    Holubiak (Myron Z) Individual Investor 1.2541 1992243 0 2022-11-30
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.8428 1338777 6154 2023-03-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3 476597 34000 2023-03-31 LOW
    Susquehanna International Group, LLP Investment Advisor 0.2893 459511 130223 2023-03-31 HIGH
    GSA Capital Partners LLP Hedge Fund 0.2849 452561 -46222 2023-03-31 LOW
    Renaissance Technologies LLC Hedge Fund 0.2513 399270 -9900 2023-03-31 HIGH
    Millennium Management LLC Hedge Fund 0.1917 304482 -246644 2023-03-31 HIGH
    Jane Street Capital, L.L.C. Research Firm 0.1549 246023 224990 2023-03-31 HIGH
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1541 244755 7008 2023-03-31 LOW
    Hightower Advisors, LLC Investment Advisor 0.1317 209198 14713 2023-03-31 LOW
    Inspire Advisors, LLC Investment Advisor 0.125 198632 2686 2023-03-31
    Wealth Advisory Solutions, L.L.C. Investment Advisor 0.0981 155850 0 2023-03-31 MED
    AHL Partners LLP Investment Advisor 0.0836 132826 86615 2023-03-31 HIGH
    Morgan Stanley & Co. LLC Research Firm 0.0759 120521 31943 2023-03-31 MED
    Qube Research & Technologies Ltd Hedge Fund 0.063 100106 -20474 2023-03-31 HIGH
    Kestra Advisory Services, LLC Investment Advisor 0.0579 91917 -1800 2023-03-31 MED

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    535K+

    Trader

    87K+

    Klien aktif per bulan

    $113M+

    Volume investasi per bulan

    $64M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Biotechnology & Medical Research (NEC)

    11 Commerce Dr Fl 1
    CRANFORD
    NEW JERSEY 07016-3501
    US

    Income Statement

    • Annual
    • Quarterly

    People also watch

    BTC/USD

    25,705.00 Price
    -2.810% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    Gold

    1,961.15 Price
    -0.240% 1D Chg, %
    Biaya inap posisi Long -0.0187%
    Biaya inap posisi short 0.0105%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    US100

    14,553.50 Price
    +0.340% 1D Chg, %
    Biaya inap posisi Long -0.0255%
    Biaya inap posisi short 0.0032%
    Waktu biaya inap 21:00 (UTC)
    Spread 3.0

    Oil - Crude

    70.46 Price
    -0.840% 1D Chg, %
    Biaya inap posisi Long -0.0193%
    Biaya inap posisi short -0.0026%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.03

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 535.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda